Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB08439ApprovedInvestigationalSmall moleculeAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors
Parecoxib is a selective COX-2 inhibitor and NSAID used for the short-term management of perioperative pain. Parecoxib is a water-soluble and injectable prodrug of valdecoxib.
- Mechanism
- Curator reviewed
Pharmacologically active on Prostaglandin G/H synthase 2 and Lactotransferrin
- Primary indication
- Used for short term perioperative pain control.Curator reviewed · 1 structured indication
- Formula / weight
- C19H18N2O4S · 370.422 g/mol (avg)
- First approval
- European Union, 2016
- Code names
- SC-69124
- Brand names
- Dynastat
Resolves to
Clinical / RWD
Structure
InChIKey
TZRHLKRLEZJVIJ-UHFFFAOYSA-NSMILESCCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C1=C(C)ON=C1C1=CC=CC=C1Targets
What you can answer from here — as of September 23, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Parecoxib, and which of those have an active Phase 3 trial?